Reviva Pharmaceuticals prices $10M public offering at $1.50
#Reviva Pharmaceuticals #public offering #$10 million #$1.50 #capital raise #pharmaceutical research #stock pricing
📌 Key Takeaways
- Reviva Pharmaceuticals priced a $10 million public offering at $1.50 per share.
- The offering aims to raise capital for the company's operations and development.
- The pricing reflects current market valuation and investor interest.
- Proceeds will support the company's pharmaceutical research and pipeline advancement.
🏷️ Themes
Finance, Pharmaceuticals
Entity Intersection Graph
No entity connections available yet for this article.